Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Francis Giles, MD
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Scripps Clinic
La Jolla, California, United States
- Usc-Norris Neuro-Oncology Program
Los Angeles, California, United States
- Ucsd Moores Cancer Center
San Diego, California, United States
- Univ. of Florida, Baptist Cancer Center
Jacksonville, Florida, United States
- Winship Cancer Institute, Emory University Hosp.
Atlanta, Georgia, United States
- University of Chicago
Chicago, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Harper Hospital - Karmanos Cancer Center
Detroit, Michigan, United States
- Univ. of Minnesota Medical Center
Minneapolis, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- New York Presbyterian Hospital-Cornell Campus
New York, New York, United States
- Wake Forest Univ. School of Medicine
Winston-Salem, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Univ. of South Carolina, Hematology/oncology Division
Charleston, South Carolina, United States
- Univ. of Texas, Md Anderson Cancer Center
Houston, Texas, United States
- University of Utah Huntsman Cancer Institute
Salt Lake City, Utah, United States
- Morgantown Internal Medicine Group
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2005
- Primary completion
- —
- Completion
- 31 Oct 2007
- Last update posted
- 3 Nov 2006
- Registered enrollment
- 211
- Registry id
- NCT00129948
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.